Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age

Cancer Research

Volumn 74, Issue 15, 2014, Pages 4078-4089

  Beaber, Elisabeth F ^a,b,c   Buist, Diana S M ^a,c   Barlow, William E ^c   Malone, Kathleen E ^b,c   Reed, Susan D ^a,b,c,d   Li, Christopher I ^b,c  

^a CENTER FOR HEALTH STUDIES   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETYNODIOL DIACETATE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; TRIPHASIC CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HEALTH CARE PLANNING; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MIDDLE AGED; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TUMOR INVASION; UNITED STATES; YOUNG ADULT; BREAST NEOPLASMS; CHEMICALLY INDUCED; CHEMISTRY;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MIDDLE AGED; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84905459984     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3400     Document Type: Article

References (38)

1. Gerstman BB, Burke L, Delaney J, McLellan B. Steroidal contraceptive use update, United States, 1989-1994. Pharmacoepidemiol Drug Saf 1996;5:141-7.
2. Gerstman BB, Gross TP, Kennedy DL, Bennett RC, Tomita DK, Stadel BV. Trends in the content and use of oral contraceptives in the United States, 1964-88. Am J Public Health 1991;81:90-6.
3. O'Brien SH, Kaizar EE, Gold MA, Kelleher KJ. Trends in prescribing patterns of hormonal contraceptives for adolescents. Contraception 2008;77:264-9.
4. Wallach M, Grimes D, editors. Modern oral contraception: updates from the contraception report. Totowa, NJ: Emron; 2000.
5. Jones J, Mosher WD, Daniels K. Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. Natl Health Stat Rep 2012;1-26.
6. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative group on hormonal factors in breast cancer. Lancet 1996;347:1713-27.
7. Breast cancer and hormonal contraceptives: further results. Collaborative group on hormonal factors in breast cancer. Contraception 1996;54:1S-106S.
8. Hunter DJ, Colditz GA, Hankinson SE, Malspeis S, Spiegelman D, Chen W, et al. Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiol Biomarkers Prev 2010;19:2496-502.
9. Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med 2002;346:2025-32.
10. Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, et al. Oral contraceptive formulation and risk of breast cancer. Contraception 2012;85:342-50.
11. Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, et al. Breast cancers among very young premenopausal women (United States). Cancer Causes Control 2003;14:151-60.
12. Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, et al. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 2009;18:1157-66.
13. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 2000;151:703-14.
14. Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, et al. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Cancer Res 2010;70:575-87.
15. Rosenberg L, Boggs DA, Wise LA, Adams-Campbell LL, Palmer JR. Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev 2010;19:2073-9.
16. Sweeney C, Giuliano AR, Baumgartner KB, Byers T, Herrick JS, Edwards SL, et al. Oral, injected and implanted contraceptives and breast cancer risk among U. S. Hispanic and non-Hispanic white women. Int J Cancer 2007;121:2517-23.
17. Saunders KW, Davis RL, Stergachis A. Group Health Cooperative. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. Chichester, England: John Wiley & Sons Ltd; 2005. p. 223-39.
18. Benagiano G, Primiero FM, Farris M. Clinical profile of contraceptive progestins. Eur J Contracept Reprod Health Care 2004;9:182-93.
19. Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, et al. Classification and pharmacology of progestins. Maturitas 2003;46 Suppl 1:S7-S16.
20. Stanczyk FZ. Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception. Rev Endocr Metab Disord 2002;3:211-24.
21. Group Health Research Institute. Group Health Breast Cancer Surveillance Registry. [cited 2013 Sep. 12]. Available from: http://www.grouphealthresearch. org/surveillanceproject/.
22. Group Health Research Institute. Group Health Cooperative Risk Factor Questionnaire 2.4. [cited 2013 Sep. 12]. Available from: http://www. grouphealthresearch.org/surveillanceproject/PDF/BSRR-Version2.4.pdf.
23. Rosenberg L, Zhang Y, Coogan PF, Strom BL, Palmer JR. A casecontrol study of oral contraceptive use and incident breast cancer. Am J Epidemiol 2009;169:473-9.
24. Ursin G, Ross RK, Sullivan-Halley J, Hanisch R, Henderson B, Bernstein L. Use of oral contraceptives and risk of breast cancer in young women. Breast Cancer Res Treat 1998;50:175-84.
25. Franke HR, Jordaan AF, Wolbers F, Vermes I, Oostrom KA, van der Mooren MJ. Ex vivo measurement of cell apoptosis and proliferation in breast tissue of healthy women: influence of age and steroid status. An exploratory study. Eur J Obstet Gynecol Reprod Biol 2006;129:96-8.
26. Isaksson E, von Schoultz E, Odlind V, Soderqvist G, Csemiczky G, Carlstrom K, et al. Effects of oral contraceptives on breast epithelial proliferation. Breast Cancer Res Treat 2001;65:163-9.
27. Garcia y Narvaiza D, Navarrete MA, Falzoni R, Maier CM, Nazario AC. Effect of combined oral contraceptives on breast epithelial proliferation in young women. Breast J 2008;14:450-5.
28. Williams G, Anderson E, Howell A, Watson R, Coyne J, Roberts SA, et al. Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 1991;48:206-10.
29. Coulter A, Vessey M, McPherson K, Crossley B. The ability of women to recall their oral contraceptive histories. Contraception 1986;33:127-37.
30. Hunter DJ, Manson JE, Colditz GA, Chasan-Taber L, Troy L, Stampfer MJ, et al. Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women. Contraception 1997;56:373-8.
31. Nischan P, Ebeling K, Thomas DB, Hirsch U. Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol 1993;138:697-703.
32. Norell SE, Boethius G, Persson I. Oral contraceptive use: interview data versus pharmacy records. Int J Epidemiol 1998;27:1033-7.
33. West SL, Strom BL, Poole C. Validity of pharmacoepidemiologic drug and diagnosis data. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. Chichester, England: John Wiley & Sons Ltd; 2005. p. 709-65.
34. Althuis MD, Brogan DR, Coates RJ, Daling JR, Gammon MD, Malone KE, et al. Hormonal content and potency of oral contraceptives and breast cancer risk among young women. Br J Cancer 2003;88:50-7.
35. Kumle M, Weiderpass E, Braaten T, Persson I, Adami HO, Lund E. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev 2002;11:1375-81.
36. White E, Malone KE, Weiss NS, Daling JR. Breast cancer among young U. S. women in relation to oral contraceptive use. J Natl Cancer Inst 1994;86:505-14.
37. Dickey RP. Managing contraceptive pill patients. 13th ed. Dallas, TX: EMIS Medical Publishers; 2007.
38. Hatcher R, Trussell J, Nelson A, Cates W, Stewart F, Kowal D. Contraceptive technology. 19th revised ed. New York: Ardent Media, Inc.; 2007.